Literature DB >> 10534311

Identification of metabolites of octamethylcyclotetrasiloxane (D(4)) in rat urine.

S Varaprath1, K L Salyers, K P Plotzke, S Nanavati.   

Abstract

Octamethylcyclotetrasiloxane (D(4)) is an industrial chemical of significant commercial importance. In this study, its major urinary metabolites were identified. The urine samples described here were collected from male and female Fischer rats (F-344) administered [(14)C]D(4) i.v. The metabolite profile was obtained using an HPLC system equipped with a radioisotope detector. HPLC analysis was performed on a C18 column, using an acetonitrile/water mobile phase. The HPLC radiochromatogram revealed two major and at least five minor metabolites. The two major metabolites, constituting 75 to 85% of the total radioactivity, were identified as dimethylsilanediol [Me(2)Si(OH)(2)] and methylsilanetriol [MeSi(OH)(3)]. Formation of MeSi(OH)(3) clearly established demethylation at the silicon-methyl bonds of D(4). No parent D(4) was present in urine. The minor metabolites identified were tetramethyldisiloxane-1,3-diol [Me(2)Si(OH)-O-Si(OH)Me(2)], hexamethyltrisiloxane-1,5-diol [Me(2)Si(OH)-OSiMe(2)-OSi(OH)Me(2)], trimethyldisiloxane-1,3,3-triol [MeSi(OH)(2)-O-Si(OH)Me(2)], dimethyldisiloxane-1,1,3,3-tetrol [MeSi(OH)(2)-O-Si(OH)(2)Me], and dimethyldisiloxane-1,1,1,3,3-pentol [Si(OH)(3)-O-Si(OH)(2)Me]. The structural assignments were based on gas chromatography-mass spectrometry analysis of the tetrahydrofuran metabolite extracts, which were derivatized using bis(trimethylsiloxy)triflouroacetamide, a trimethylsilylating agent. The structures were confirmed by synthesizing (14)C-labeled standards and comparing their HPLC radiochromatograms with the corresponding components in the rat urine. GC-MS spectral comparisons of the trimethylsilylated derivatized standards and urinary components also were made to further confirm their identities. Finally, several of the urinary metabolites were fractionated using HPLC, and GC-MS comparisons were again made for positive structural identification. The pathways for metabolite formation are not yet understood, but a mechanistic hypothesis has been proposed to account for the various metabolites observed thus far.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10534311

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  5 in total

1.  Assessing two-way interactions between cells and inorganic nanoparticles.

Authors:  C Cristallini; N Barbani; S Bianchi; S Maltinti; A Baldassare; R Ishak; M Onor; L Ambrosio; V Castelvetro; M G Cascone
Journal:  J Mater Sci Mater Med       Date:  2019-12-05       Impact factor: 3.896

2.  Risk Assessment of Food Contact Materials II.

Authors:  Edoardo Galbiati; Thomas Tietz; Sebastian Zellmer; Stefan Merkel
Journal:  EFSA J       Date:  2022-05-25

3.  Inhalation dosimetry modeling with decamethylcyclopentasiloxane in rats and humans.

Authors:  Micaela B Reddy; Ivan D Dobrev; Debra A McNett; Joseph M Tobin; Mark J Utell; Paul E Morrow; Jeanne Y Domoradzki; Kathleen P Plotzke; Melvin E Andersen
Journal:  Toxicol Sci       Date:  2008-06-26       Impact factor: 4.849

4.  Silanetriols as in vitro inhibitors for AChE.

Authors:  Martina Blunder; Natascha Hurkes; Stefan Spirk; Martina List; Rudolf Pietschnig
Journal:  Bioorg Med Chem Lett       Date:  2010-11-05       Impact factor: 2.823

5.  Characterization of in vivo metabolites in rat urine following an oral dose of masitinib by liquid chromatography tandem mass spectrometry.

Authors:  Adnan A Kadi; Sawsan M Amer; Hany W Darwish; Mohamed W Attwa
Journal:  Chem Cent J       Date:  2018-05-15       Impact factor: 4.215

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.